Aristolochia Renal Disease Link Reported In Two U.S. Cases
This article was originally published in The Tan Sheet
Executive Summary
Aristolochic acid-containing botanicals were used by two individuals in the U.S. who developed end-stage renal disease, FDA reports in an April 4 letter urging health professionals to more closely monitor their patients' dietary supplement intake.
You may also be interested in...
Chinese herbal recall
New York City-based Kingsway Trading Inc. is voluntarily recalling two of its Chinese herbal supplements because they contain aristolochic acid; the ingredient was found in Kingsway Trading's Expellin Extract and Cardioflex. Aristolochic acid has been linked to an increased risk of kidney cancer and in some cases kidney failure (1"The Tan Sheet" April 16, 2001, p. 9). An FDA district office in New York collected samples during a routine inspection and subsequent testing revealed the presence of the ingredient. The company issued a recall letter to customers Nov. 12...
Chinese herbal recall
New York City-based Kingsway Trading Inc. is voluntarily recalling two of its Chinese herbal supplements because they contain aristolochic acid; the ingredient was found in Kingsway Trading's Expellin Extract and Cardioflex. Aristolochic acid has been linked to an increased risk of kidney cancer and in some cases kidney failure (1"The Tan Sheet" April 16, 2001, p. 9). An FDA district office in New York collected samples during a routine inspection and subsequent testing revealed the presence of the ingredient. The company issued a recall letter to customers Nov. 12...
Chinese herbal recall
New York City-based Kingsway Trading Inc. is voluntarily recalling two of its Chinese herbal supplements because they contain aristolochic acid; the ingredient was found in Kingsway Trading's Expellin Extract and Cardioflex. Aristolochic acid has been linked to an increased risk of kidney cancer and in some cases kidney failure (1"The Tan Sheet" April 16, 2001, p. 9). An FDA district office in New York collected samples during a routine inspection and subsequent testing revealed the presence of the ingredient. The company issued a recall letter to customers Nov. 12...